Elevance Health (ELV) Other financing activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Other financing activities data on file, last reported at $12.0 million in Q2 2026.

• On a quarterly basis, Other financing activities rose 135.29% year-over-year to $12.0 million in Q2 2026; TTM through Jun 2026 was $99.0 million, a 50.99% decrease from a year earlier, with the FY2025 full-year figure at $79.0 million, down 64.25% from the prior year.
• Other financing activities for Q2 2026 stood at $12.0 million, up from -$3.0 million in the prior quarter.
• Over the last five years, Other financing activities for ELV reached as high as $197.0 million in Q3 2024 and fell as low as -$100.0 million in Q3 2022.
• Historically, Other financing activities has averaged $35.7 million across 5 years, with a median of $22.0 million in 2025.
• On a YoY basis, Other financing activities climbed as much as 475.0% in 2025 and fell as far as 950.0% in 2025.
• Year by year, Other financing activities stood at $166.0 million in 2022, then declined by 11.45% to $147.0 million in 2023, then tumbled by 89.12% to $16.0 million in 2024, then soared by 331.25% to $69.0 million in 2025, then tumbled by 82.61% to $12.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $12.0 million in Q2 2026, -$3.0 million in Q1 2026, and $69.0 million in Q4 2025.